申请人:Eli Lilly and Company
公开号:US05281624A1
公开(公告)日:1994-01-25
This invention provides N-alkyl-3-phenyl-3-(2-substituted phenoxy)propylamines which are useful to treat neurological disorders associated with norepinephrine imbalance.
这项发明提供了N-烷基-3-苯基-3-(2-取代苯氧基)丙胺,可用于治疗与去甲肾上腺素失衡相关的神经系统疾病。